Connect with us

Technology

GenScript Announces 4th Annual Gene & Cell Engineering Virtual Summit

Published

on

GenScript, the leading biotech company focused on early drug discovery and development services, is excited to announce its upcoming virtual event, the “GenScript 4th Annual Gene and Cell Engineering Summit,” on July 24, 2024.

PISCATAWAY, N.J., July 15, 2024 /PRNewswire-PRWeb/ — GenScript the leading biotech company focused on early drug discovery and development services, is excited to announce its upcoming virtual event, the “GenScript 4th Annual Gene and Cell Engineering Summit,” on July 24, 2024.

Join GenScript for this one-day event featuring keynote presentations from invited speakers specializing in Cell and Gene Therapy research.

This event will feature leading experts from academia, pharma, and biotech, showcasing the transformative power of synthetic biology in developing life-changing therapies. Synthetic biology is revolutionizing life science research, advancing gene and cell therapies, and facilitating the efficient development of biotherapeutics for various human diseases.

Committed to “Making People and Nature Healthier through Biotechnology,” GenScript partners with scientists globally to facilitate research and expedite discoveries through its advanced platforms. Join us for this one-day event featuring keynote presentations from invited speakers specializing in Cell and Gene Therapy research.

The exciting lineup includes:

Opening remarks and an introduction to the event program by Ms. Sherry Shao, Rotating CEO of GenScript Biotech.Dr. Jason Zhang, Co-Founder and CEO of Zipcode Bio, presents first on “Exploring the Development & Optimization of mRNA Delivery Systems to Advance mRNA-based Medicines.” This keynote will provide an exploration of these approaches, highlighting the progress made and the future directions for this promising field.Dr. Samuel H. Sternberg, Associate Professor in the Department of Biochemistry and Molecular Biophysics at Columbia University, highlights an elegant expansion of genome coding potential through RNA-templated gene creation, and challenges conventional paradigms of genetic information encoded along the one-dimensional axis of genomic DNA in his presentation “De novo gene synthesis by an antiviral reverse transcriptase.”Dr. Branden Moriarty, Associate Professor at the University of Minnesota Medical School, will discuss the limitations of immunotherapy using chimeric antigen receptor (CAR) expressing NK cells engineered via viral vectors and the methods to overcome these shortcomings in his presentation “Cytokine Armored CAR-NK Cell Therapy for Advanced Ovarian Cancer.”Dr. Sandeep Kumar, Senior Director of Platform Development at Tome Biosciences, will present on “Programmable Genomic integration (PGI): a technology that enables the integration of large DNA sequences at specific genomic locations.” His talk will provide an overview of PGI and highlight the progress Tome has made in developing this technology into medicine for patients in need.Dr. Fred Parietti, Co-founder and CEO of Multiply Labs, will present on “The Power of Automation: How Robotics Can Dramatically Reduce Cell Therapy Manufacturing Costs and Scale Patient Access.” This talk will explore the cutting-edge developments made this year in finally bringing automation to cell therapy manufacturing.Dr. Michelle Hung, Principal Scientist at GeneFab, will present several case studies of how GeneFab’s team has delivered on complex projects to enable their clients to develop next-generation pipeline products in her talk “Synthetic biology approaches to improve cell therapy function.”Dr. Sergej Kudruk, Postdoctoral Fellow at Northwestern University and the International Institute for Nanotechnology, will present on “Advancing Gene Editing Technologies with Spherical Nucleic Acids (SNA).” Here he will discuss the important work that underscores the precise control over molecular interactions at the nanoscale and the potential of SNA-based nanotechnologies for gene editing applications.Dr. Dong Geng, the VP, Head of Early-stage Drug Development at Legend Biotech will discuss how cell therapies targeting autoreactive immune cells may offer a potentially curative approach in certain autoimmune diseases in her presentation “Autoimmune Diseases, the Arising Opportunities for Cell Therapies.”Finally, Dr. Raymond Miller, Director of Brand Management, GenScript USA Inc, will deliver closing remarks for the day.

The event is tailored for life science researchers, laboratory professionals, pathologists, and anyone involved in gene and cell engineering. In addition to the presentations, attendees can participate in interactive sessions, visit the exhibit hall, chat with attendees in the networking lounge, and engage in real-time Q&A sessions with expert speakers.

For further information about the event and to register for free, click here.

About GenScript
As a leading contract research organization (CRO), GenScript, headquartered in Piscataway, New Jersey, provides comprehensive solutions for researchers worldwide, offering services in gene synthesis, peptide synthesis, protein engineering, CRISPR tools, mRNA synthesis, custom antibody generation, and more. Since 2001, GenScript has expanded its capabilities through strategic growth and partnerships, establishing itself as a leader in biological research services.

GenScript is dedicated to making research easy, offering complete solutions for investigators developing gene and cell therapies through viral, non-viral CRISPR, and mRNA strategies. For more information, please visit http://www.genscript.com.

About Labroots
Labroots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities. Founded in 2008, Labroots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events.

Media Contact

Akshay Masand, Labroots, 1-714-463-4673, akshay.masand@labroots.com, www.labroots.com

View original content to download multimedia:https://www.prweb.com/releases/genscript-announces-4th-annual-gene–cell-engineering-virtual-summit-302197353.html

SOURCE Labroots

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Reliance Digital Brings Samsung’s Latest Galaxy Z Fold8 Series and Galaxy Z Flip8 to Stores Across India

Published

on

By

Be among the first to own the new Samsung Galaxy Z Fold8 series and Galaxy Z Flip8. Customers can now pre-order the latest Galaxy foldables at Reliance Digital, with EMIs starting at ₹6000/month.

MUMBAI, India, July 25, 2026 /PRNewswire/ — Reliance Digital, India’s leading consumer electronics retailer, today announced the availability of Samsung’s latest generation of foldable smartphones – the Galaxy Z Fold8 Ultra, Galaxy Z Fold8 and Galaxy Z Flip8. Designed to deliver the next evolution of Galaxy AI, powerful performance and iconic foldable innovation, Samsung’s newest line-up is now available across Reliance Digital stores and online.

Built around Samsung’s vision of making AI more intuitive and personal, the new Galaxy foldables combine immersive displays, premium craftsmanship and intelligent experiences that seamlessly adapt to the way users work, create and stay connected.

Leading the line-up is the Galaxy Z Fold8 Ultra, Samsung’s most premium foldable yet. Featuring an expansive 8-inch Dynamic AMOLED 2X main display, a flagship 200MP camera, the latest Snapdragon® 8 Elite Gen 5 for Galaxy processor and a 5,000mAh battery, the device is engineered for users who demand the ultimate in productivity, creativity and entertainment. It is available in Graphite, Cream and Violet Shadow,.

The Galaxy Z Fold8 brings Samsung’s signature foldable experience in a more compact form factor, featuring a 7.6-inch Dynamic AMOLED 2X main display, a redesigned wider cover screen, Galaxy AI-powered multitasking and flagship-grade performance. Customers can choose from Lavender, Graphite and Cream colour options.

Completing the line-up is the Galaxy Z Flip8, Samsung’s most stylish foldable smartphone, designed for users who want flagship performance in a compact, pocket-friendly form. Equipped with a vibrant 6.9-inch Dynamic AMOLED 2X display, an enhanced FlexWindow, a 50MP camera system and Galaxy AI experiences, the Flip8 effortlessly blends fashion with functionality.

Customers can visit their nearest Reliance Digital store to experience the new foldables first-hand with guidance from Reliance Digital’s Tech Dosts, compare models, explore exclusive launch offers and Pre-order the Galaxy device that best fits their lifestyle. The complete Galaxy Z Fold8 series and Galaxy Z Flip8 are also available through Reliance Digital’s online platform, ensuring customers can be among the first to own Samsung’s latest foldable innovations.

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/reliance-digital-brings-samsungs-latest-galaxy-z-fold8-series-and-galaxy-z-flip8-to-stores-across-india-302834321.html

Continue Reading

Technology

Weichai’s Five Tech Routes Global Debut: Diverse Paths to a Green, Smart Future

Published

on

By

HANOI, Vietnam, July 25, 2026 /PRNewswire/ — At VEC in Vietnam on July 21, the Shandong Heavy Industry global partners conference & green intelligent products expo opened. Responding to the green transition of global commercial vehicles and heavy equipment, Weichai – with decades of expertise – unveiled five core tech routes: BEV, HEV, PEMFC, alternative-fuel ICE, and ADAS. Through full-chain proprietary control and breakthroughs, it provides efficient, low-carbon, intelligent power solutions to the global market.

Battery electric vehicle powertrain: full-chain deployment and high-efficiency recharging: Weichai masters core battery, motor, and e‑control technologies. Its CT100 battery – for heavy tractors and dump trucks – features integrated design and triple insulation, delivering better reliability, efficiency, safety, and speed. The WMS3200 drive system, tailored for heavy‑truck haulage, boosts efficiency and cuts vehicle power consumption. The WMC‑L/H/B integrated controllers offer stable, efficient control for light trucks, heavy trucks, and buses.

Hybrid electric vehicle powertrain: deep integration and ultra-long range: Weichai covers series, parallel, and series-parallel architectures, deeply integrating engine and e-drive. For urban logistics, the WP2.5T range extender offers quick response and low noise; for long-haul transport, the WP3NNG natural-gas range extender uses a “pure electric for short hauls, range-extended for long hauls” mode, with over 1,000 km combined range, easing range anxiety.

Proton exchange membrane fuel cell: zero-carbon leadership: Weichai has built a full-chain hydrogen energy system covering components, stacks, and systems. The WEF300 fuel cell engine has been deployed in volume in 49-ton heavy-duty trucks, suitable for long-haul and port logistics. The WEFG500 power generation system provides megawatt-class scalable power to support data centers and industrial plants.

Alternative fuel internal combustion engine: diverse clean-energy options and exceptional cost-effectiveness: Modular design enables flexible switching between H₂ and methanol. WP15DI hydrogen ICE peaks at 46.8% thermal efficiency; WP17T methanol ICE targets heavy‑equipment energy use, cuts operating costs, and is mass‑deployed in 130‑ton mining trucks.

Intelligent driving assistance system: vehicle-road-cloud collaboration: Weichai built a vehicle‑road‑cloud full‑stack architecture, with mining autonomous solution for cm‑level docking & obstacle avoidance, and trunk‑line ADAS with intelligent cruise & auto lane‑change, boosting high‑speed safety and economy.

Going forward, Weichai will keep iterating these five tech routes with global partners to advance sustainable manufacturing.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/weichais-five-tech-routes-global-debut-diverse-paths-to-a-green-smart-future-302834548.html

SOURCE Weichai Group

Continue Reading

Technology

Portland General Electric declares dividend

Published

on

By

PORTLAND, Ore., July 24, 2026 /PRNewswire/ — The board of directors of Portland General Electric Company (NYSE: POR) declared a quarterly common stock dividend of $0.55125 per share.

The company’s dividend is evaluated based on capital requirements and financial performance. PGE targets a dividend payout ratio of 60 to 70% over the long term.

The quarterly dividend is payable on or before October 15, 2026, to shareholders of record at the close of business on September 25, 2026.

About Portland General Electric Company
Portland General Electric (NYSE: POR) is an integrated energy company that generates, transmits and distributes electricity to nearly 960,000 customers serving an area of approximately 2 million Oregonians. Since 1889, Portland General Electric (PGE) has been powering economies, delivering safe, affordable and reliable electricity while working to transform energy systems to meet evolving customer needs. PGE continues to make progress towards emissions reduction targets, and customers have set the standard for prioritizing clean energy with the No. 1 voluntary renewable energy program in the country. PGE is ranked a top ten utility in the 2025 Forrester U.S. Customer Experience Index. In 2025, PGE employees and retirees volunteered over 18,300 hours to more than 400 nonprofits organizations. Through the PGE Foundation, along with corporate contributions and the employee matching gift program, more than $5 million was directed to charitable organizations supporting economic growth and community resilience across our service area. For information: portlandgeneral.com/news.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on assumptions about the future, involve risks and uncertainties, and are not guarantees. Future results may differ materially from those expressed or implied in any forward-looking statement. These forward-looking statements represent our estimates and assumptions only as of the date of this press release. We assume no obligation to update or revise any forward-looking statement as a result of new information, future events or otherwise.

Forward-looking statements include statements, other than statements of historical or current fact, regarding the Company’s amount and timing of dividends payable as well as other statements containing words such as “committed to,” “targets,” or similar expressions.

There can be no assurance that future dividends will be declared. The declaration of future dividends is subject to approval of our board of directors and various risks and uncertainties, including, but not limited to: our cash flow and cash needs; the timing or amount of dividends paid; the timing or outcome of various legal and regulatory actions; changes in the Company’s business strategy; increases in capital expenditures; changes in capital and credit market conditions, including volatility of equity markets as well as changes in PGE’s credit ratings and outlook on such credit ratings restrictions on the payment of dividends under existing or future financing arrangements; changes in tax laws relating to corporate dividends; deterioration in our financial condition or results, and those risks, uncertainties, and other factors identified from time-to-time in our filings with the United States Securities and Exchange Commission (SEC), including our annual report on Form 10-K for the year ended December 31, 2025 and subsequent quarterly reports on Form 10-Q. These reports are available through the EDGAR system free-of-charge on the SEC’s website, www.sec.gov and on the Company’s website, investors.portlandgeneral.com. Investors should not rely unduly on any forward-looking statements. The Company assumes no obligation to update or revise any forward-looking statement as a result of new information, future events or other factors.

Media Contact:
Drew Hanson
Corporate Communications
Phone: 503-464-2067

Investor Contact:
Erin Schwartz
Investor Relations
Phone: 503-464-7751

View original content:https://www.prnewswire.com/news-releases/portland-general-electric-declares-dividend-302834503.html

SOURCE Portland General Company

Continue Reading

Trending